Evidence map›Paper›PMID 33517540›Full record

ArticleJournal of molecular modeling2021

DFT study of structural and electronic properties of 1,4-diarylcyclopenta[d] pyridazines and oxazines for non-linear optical applications.

Steven Wild, Nathan Tice

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Steven WildDepartment of Physical Sciences, University of Findlay, Findlay, OH, 45840, USA. wild@findlay.edu.ORCID http://orcid.org/0000-0001-8257-8591
Nathan TiceDepartment of Physical Sciences, University of Findlay, Findlay, OH, 45840, USA.
University of Findlay · US

Funding

University of Findlay Departmental FundingUniversity of Findlay ETS grant
6 · The paper itself

Abstract

Polymer and molecular-based electronic materials incorporating heterocycles like thiophenes and pyrroles are attractive possibilities as substitutes for semimetal materials. Heterocyclic materials are heavily studied in this regard due to the large variations in possible substrates. Herein we evaluated four different 5,6-fused ring heterocycles to gain a better understanding of any favorable optical and electronic properties that were due to incorporation of certain moieties. The molecules chosen would highlight the effects that the central ring (pyridazine versus oxazine), aromatic substituent, and heterocyclic side group may have on electronic and optical properties. Computational analysis of these four molecules was done using density functional theory (B3LYP and PBEPBE) with 6-31G(d,p), 6-311 ++G(d,p), and cc-pVTZ basis sets. The constituent molecules were optimized, and calculations were done for the dipole moment, polarizability, first-order hyperpolarizability (β), HOMO and LUMO orbitals, and a natural bonding order (NBO) analysis. These calculations allow for the study of charge density via electrostatic potential mapping and bonding orbitals. The results indicated that the pyridazine molecules presented here are more favorable than the oxazines for non-linear optical (NLO) applications. It is also noted that side ring substituents (thienyl and furyl) in the two pyridazines studied showed very little calculated differences. Finally, heterocyclic rings showed more favorable properties when incorporated as substituents for NLO applications over hydrocarbon aromatics. Graphical abstract.

Indexed as

Electronic materialsNon-linear opticsOxazinesPyridazines

Identifiers

PMID33517540
OpenAlexW3126938332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.